Medifast stock analysis
Medifast (0K05) Share Price & Analysis
0K05 Stock Chart & Stats
- Day’s Range
- $12.53 - $13.10
- 52-Week Range
- $9.27 - $13.54
- Previous Close
- $12.86
- Volume
- N/A
- Average Volume (3M)
- 229
- Market Cap
- $145.04M
- Enterprise Value
- -$23.04M
- Total Cash (Recent Filing)
- $172.53M
- Total Debt (Recent Filing)
- $20.68M
- Price to Earnings (P/E)
- ―
- Beta
- 0.55
- Next Earnings
- Feb 23, 2027 (Est.)
- EPS Estimate
- 0.01
- Last Dividend Ex-Date
- Sep 18, 2023
- Dividend Yield
- N/A
Bulls Say, Bears Say
Bulls Say
Debt-free Balance Sheet
The debt-free balance sheet and substantial cash reserve provide financial flexibility while Medifast restructures its cost base and invests in growth initiatives. This liquidity reduces near-term financing pressure and gives management capacity to support the Trilogy transition despite current operating losses.
Improving Coach Productivity
Repeated year-over-year productivity gains indicate that the coach network is generating more revenue per active participant, partially offsetting its smaller size. If sustained, higher productivity can improve customer economics, strengthen coach engagement, and support eventual revenue stabilization.
Metabolic Health Product Expansion
The move from traditional weight management toward a broader metabolic health system expands the company’s product positioning and customer conversation. New formulations, training, and multi-phase programs could improve differentiation and retention if adoption continues across the coach network.
Bears Say
Sharp Revenue Contraction
The prolonged revenue decline shows that Medifast has not yet stabilized demand after the business contracted substantially. A smaller sales base reduces operating leverage, limits reinvestment capacity, and makes a durable return to profitability dependent on reversing the underlying customer and coach trends.
Shrinking Coach Network
The sharp reduction in active earning coaches weakens Medifast’s primary customer-acquisition and support channel. Management expects the decline to continue in the near term, creating a structural risk that productivity gains will be insufficient to offset fewer coaches and constrain future revenue growth.
Losses And Weak Cash Generation
Persistent operating and net losses, combined with slightly negative free cash flow, show that the current revenue base is not covering the company’s cost structure. Continued losses can erode equity and cash reserves over time, increasing execution pressure even though leverage remains low.
Medifast News
0K05 FAQ
What was Medifast’s price range in the past 12 months?
What is Medifast’s market cap?
When is Medifast’s upcoming earnings report date?
How were Medifast’s earnings last quarter?
Is Medifast overvalued?
Does Medifast pay dividends?
What is Medifast’s EPS estimate?
How many shares outstanding does Medifast have?
What happened to Medifast’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Medifast?
What is the TipRanks Smart Score and how is it calculated?
Medifast Stock Smart Score
Company Description
Medifast
Medifast, Inc., through its various divisions, develops and provides a range of consumable health and nutritional items tailored for weight loss, weight management, and general wellness. These products are distributed across the United States and the Asia-Pacific region. Their extensive portfolio encompasses snack bars, savory bites, cereals, drinks, substantial meal choices, oatmeal, pancakes, puddings, soft serves, shakes, smoothies, baked goods, and soups. These offerings are marketed under proprietary brands like OPTAVIA, Optimal Health by Take Shape for Life, and Flavors of Home. The company facilitates sales primarily through direct e-commerce transactions. Established in 1980, Medifast, Inc. maintains its corporate headquarters in Baltimore, Maryland.
- Sector
- Consumercyclical
- Industry
- Personal Products & Services
- CEO
- Nicholas Johnson
- Employees
- 380
- Website
- medifastinc.com
- Address
- 1501 S. Clinton Street, Baltimore, MD, 21224, US
Medifast (0K05) Earnings & Revenues
0K05 Company Deck
0K05 Earnings Call
Earnings Call SentimentNeutral
The call was cautiously positive. Management highlighted successful execution of the Trilogy 3.0 launch, improving coach productivity, strong product adoption, a debt-free balance sheet, cost realignment, and a stated path to fourth-quarter profitability. However, these positives were offset by a 19.4% revenue decline, a substantial reduction in active earning coaches, continued GLP-1-related pressure on the traditional weight loss category, and significantly larger GAAP operating and net losses. The outlook is constructive but remains dependent on improving coach growth while sustaining productivity gains.
View all GB:0K05 earnings summaries0K05 Stock 12 Month Forecast
Average Price Target
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 11 | 6 | 5 |
| Technical Analysis | 3 | 6 | 1 |
| Moving Averages | 8 | 0 | 4 |









